Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
34 participants
INTERVENTIONAL
2014-02-28
2015-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Rubus Occidentalis Extract on Plasma Glucose Levels in Subject With Prediabetes
NCT01964703
Effect of Mulberry Leaf Extract on Blood Glucose
NCT01385865
Reduction of the Dietary Glycemic Index (GI) by L-Arabinose and Indigestible Dextrin
NCT01039662
Impact of Mulberry Leaf on Type 2 Diabetes
NCT00795704
Effect of Anthocyanins on Metabolic Profiles in Subjects With Pre-diabetes
NCT02689765
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Treatment sequence 1
PLE (persimmon leaf extract) once a day during 8 weeks cross-over to placebo once a day during 8 weeks.
Persimmon leaf extract
Persimmon leaf extract (PLE), crossover design
Placebo
Placebo, crossover design
Treatment sequence 2
Placebo once a day during 8 weeks cross-over to PLE once a day during 8 weeks.
Persimmon leaf extract
Persimmon leaf extract (PLE), crossover design
Placebo
Placebo, crossover design
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Persimmon leaf extract
Persimmon leaf extract (PLE), crossover design
Placebo
Placebo, crossover design
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Fasting blood glucose (FPG) 100\~140 mg/dL or postprandial blood glucose (PPG) 140\~250 mg/dL
Exclusion Criteria
* 2h PPG more than 200 mg/dL
* Type 1 diabetes or HbA1c more than 9.0%
* treatment with corticosteroids within the past 4 weeks
* cardiovascular disease
20 Years
75 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Chonbuk National University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Soo-Wan Chae
Professor
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
WJG-HG-PLE
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.